OIM
Oracle Investment Management Portfolio holdings
AUM
$143M
1-Year Est. Return
55.89%
1 Year Est. Return
+55.89%
AUM
$116M
AUM Growth
-$38M
(-25%)
Holding
14
Top Sells
| 1 | +$23.4M | |
| 2 | +$4.38M | |
| 3 | +$3.82M | |
| 4 |
Teladoc Health
TDOC
|
+$1.61M |
| 5 |
Recursion Pharmaceuticals
RXRX
|
+$635K |
Sector Composition
| 1 | Healthcare | 95.16% |
| 2 | Technology | 3.48% |
| 3 | Consumer Discretionary | 1.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
GeneDx Holdings
WGS
$4.48B
| $85.2M | 58.4% |
922,454
-47,500
|
|
||
2
Biohaven
BHVN
$1.53B
| $9.5M | 6.51% |
673,166
+7,221
|
|
||
3
Ardelyx
ARDX
$1.43B
| $5.61M | 3.85% |
1,430,728
-973,710
|
|
||
4
Palantir
PLTR
$445B
| $4.02M | 2.76% |
29,500
|
|
||
5
QuidelOrtho
QDEL
$2.05B
| $3.41M | 2.34% |
118,291
|
|
||
|
6
Teladoc Health
TDOC
$1.35B
| $3.32M | 2.28% |
381,000
-184,900
|
|
||
7
Forian
FORA
$66.8M
| $2.68M | 1.84% |
1,366,107
|
|
||
8
CAVA Group
CAVA
$6.18B
| $1.57M | 1.07% |
18,600
|
|
||
9
Biogen
BIIB
$25.8B
| $303K | 0.21% |
2,412
|
|
||
10
Peloton Interactive
PTON
$2.78B
| – | – |
0
|
|
||
|
11
Recursion Pharmaceuticals
RXRX
$2.4B
| – | – |
-120,000
|
|
||
|
SWTX
12
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-531,351
|
|
||
13
Viking Therapeutics
VKTX
$4.25B
| – | – |
0
|
|
||
14
State Street SPDR NYSE Technology ETF
XNTK
$1.51B
| – | – |
0
|
|